Close

Rating History for Halozyme Therapeutics (HALO) by UBS

More Stocks Rated by UBS | Latest Ratings for HALO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/20/2016 N/A Maintain Buy
(Buy)		 22.00
(28.00)		  
 		   Details